The rhodium and iridium Lewis-acid cations [(eta(5)-C(5)Me(5))M{(R)-Prophos}(H(2)O)](2+) ((R)-Prophos = 1,2-bis(diphenylphosphino)propane) efficiently catalyze the enantioselective 1,3-dipolar cycloaddition of nitrones to methacrolein. Reactions occur with perfect endo selectivity and with enantiomeric excesses up to 96%. Intermediates [(eta(5)-C(5)Me(5))M{(R)-Prophos}(methacrolein)](SbF(6))(2) (M = Rh (3), Ir (4)) have been spectroscopically and crystallographically characterized. The nitrone complexes [(eta(5)-C(5)Me(5))M{(R)-Prophos}(nitrone)](SbF(6))(2) (M = Rh, nitrone = 1-pyrrolidine N-oxide (5), 2,3,4,5,-tetrahydropyridine N-oxide (6), 3,4-dihydroisoquinoline N-oxide (7); M = Ir, nitrone = 1-pyrrolidine N-oxide (8)) have been isolated and characterized including the X-ray crystal structure of compounds 6 and 8. The equilibrium between methacrolein and nitrone complexes is also studied. [Ir]-adduct complexes are detected by (31)P NMR spectroscopy. A catalytic cycle involving [M]-methacrolein, [M]-nitrone, as well as [M]-adduct species is proposed, the first complex being the true catalyst. The absolute configuration of the adduct 4-methyl-2-N,3-diphenyl-isoxazolidine-4-carbaldehyde (9) was determined through its (S)-(-)-alpha-methylbenzylamine derivative diastereomer. Structural parameters strongly suggest that the disposition of the methacrolein in 3 and 4 is fixed by CH/pi attractive interactions between the pro-S phenyl ring of the Ph(2)PCH(CH(3)) moiety of the (R)-Prophos ligand and the CHO aldehyde proton. Proton NMR data indicate that this conformation is maintained in solution. From the structural data and the results of catalysis the origin of the enantioselectivity is discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.